Logo-jre

   
J Ren Endocrinol. 2022;8: e25072 | Published on: 2022 Dec 28. doi: 10.34172/jre.2022.25072

Mini-Review

Colchicine and the concepts of nephroprotection; a new feature of an old drug

Hamid Nasri * ORCID

Cited by CrossRef: 0

1- Nidorf S, Ben-Chetrit E, Ridker P. Low-dose colchicine for atherosclerosis: long-term safety. 2024;45(18):1596 [Crossref]
2- Iqbal Lone W, Chand J, Kumar P, Garg Y, Ahmed Z, Mukherjee D, Goswami A, Momo H. Anãl J. Discovery of colchicine aryne cycloadduct as a potent molecule for the abrogation of epithelial to mesenchymal transition via modulating cell cycle regulatory CDK-2 and CDK-4 kinases in breast cancer cells. Bioorganic Chemistry. 2024;150:107581 [Crossref]